FDA.reportPublic FDA data

LATANOPROST - Food and Drug Administration

Set ID
f6b0b05b-3bf2-088a-8ccc-e1cf01a91e86
Type
Indexing - Product Concept
Effective date
2025-07-29
Version
4
Source
DailyMed source

Mapped DailyMed Labels#

Label, Relation, Manufacturer table
LabelRelationManufacturerEffective
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION, for topical ophthalmic use Initial U.S. Approval: 1996Product nameLifestar Pharma LLC | Mankind Pharma Limited2026-09-08
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, 0.005% Initial U.S. Approval: 1996Product nameNuCare Pharmaceuticals,Inc.2026-09-04
These highlights do not include all the information needed to use ROCKLATAN ® safely and effectively. See full prescribing information for ROCKLATAN ® . ROCKLATAN ® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%, for topical ophthalmic use Initial U.S. Approval: 2019Product nameAlcon Laboratories, Inc. | Alcon Research LLC2026-08-27
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, 0.005% Initial U.S. Approval: 1996Product nameNuCare Pharmaceuticals,Inc.2026-03-02
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameMicro Labs Limited2026-01-21
These highlights do not include all the information needed to use ROCKLATAN ® safely and effectively. See full prescribing information for ROCKLATAN ® . ROCKLATAN ® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%, for topical ophthalmic use Initial U.S. Approval: 2019Product nameAlcon Laboratories, Inc. | Alcon Research LLC2026-01-20
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION . LATANOPROST Ophthalmic Solution 0.005%, for topical ophthalmic use Initial U.S. Approval:1996Product nameRising Pharma Holdings, Inc. | FDC Limited2026-01-02
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameLifestar Pharma LLC | Mankind Pharma Limited2025-12-29
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameSomerset Therapeutics, LLC | Somerset Therapeutics Private Limited2025-12-22
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameGLENMARK PHARMACEUTICALS INC | GLAND PHARMA LIMITED2025-12-18
These highlights do not include all the information needed to use XELPROS safely and effectively. See full prescribing information for XELPROS. XELPROS ® (latanoprost ophthalmic emulsion) 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameSun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited2025-12-18
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameBausch & Lomb Incorporated2025-10-23
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameNuCare Pharmaceuticals, Inc.2025-08-13
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameSagent Pharmaceuticals2025-06-26
These highlights do not include all the information needed to use LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION. LATANOPROSTENE BUNOD ophthalmic solution. Initial U.S. Approval: 2017Product nameGland Pharma Limited2025-05-02
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameA-S Medication Solutions2025-01-09
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST OPHTHALMIC SOLUTION 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameGland Pharma Limited2024-11-29
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996Product nameProficient Rx LP2024-10-01
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 1996Product nameAurobindo Pharma Limited | EUGIA PHARMA SPECIALITIES LIMITED2024-09-27
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION . LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameMylan Pharmaceuticals Inc.2024-09-15
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION . LATANOPROST Ophthalmic Solution 0.005%, for topical ophthalmic use Initial U.S. Approval:1996Product nameRising Pharma Holdings, Inc. | FDC Limited2024-08-07
These highlights do not include all the information needed to use IYUZEH safely and effectively. See full prescribing information for IYUZEH. IYUZEH (latanoprost ophthalmic solution) 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameThea Pharma Inc.2024-07-30
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameA-S Medication Solutions2024-02-27
These highlights do not include all the information needed to use VYZULTA safely and effectively. See full prescribing information for VYZULTA. VYZULTA ® (latanoprostene bunod ophthalmic solution) 0.024%, for topical ophthalmic use Initial U.S. Approval: 2017Product nameBausch & Lomb Incorporated2024-02-27
These highlights do not include all the information needed to use XALATAN safely and effectively. See full prescribing information for XALATAN . XALATAN ® (latanoprost ophthalmic solution) 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameViatris Specialty LLC2023-05-15
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameBausch & Lomb Incorporated2023-04-17
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product nameSandoz Inc2023-01-31
These highlights do not include all the information needed to use XALATAN safely and effectively. See full prescribing information for XALATAN. XALATAN ® (latanoprost ophthalmic solution) 0.005%, for topical ophthalmic use Initial U.S. Approval: 1996Product namePFIZER LABORATORIES DIV PFIZER INC2022-12-27
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996Product nameNuCare Pharmaceuticals,Inc.2022-02-07
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1996Product nameNuCare Pharmaceuticals,Inc.2021-02-17
These highlights do not include all the information needed to use Latanoprost Ophthalmic Solution safely and effectively. See full prescribing information for Latanoprost Ophthalmic Solution. Latanoprost Ophthalmic Solution 0.005% Initial U.S. Approval:1996.Product nameNuCare Pharmaceuticals,Inc.2021-01-29
LATANOPROSTProduct nameDIRECT RX2020-01-20
These highlights do not include all the information needed to use Latanoprost Ophthalmic Solution safely and effectively. See full prescribing information for Latanoprost Ophthalmic Solution. Latanoprost Ophthalmic Solution 0.005% Initial U.S. Approval:1996Product nameFDC Limited2019-11-29
ImprimisRx NJ human prescription drug labelProduct nameImprimisRx NJ2018-05-08
ImprimisRx NJ human prescription drug labelProduct nameImprimisRx NJ2018-05-08
ImprimisRx NJ human prescription drug labelProduct nameImprimisRx NJ2018-05-08
ImprimisRx NJ | Imprimis Pharmaceuticals human prescription drug labelProduct nameImprimisRx NJ | Imprimis Pharmaceuticals2018-05-08
Xalatan ® latanoprost ophthalmic solution 0.005% (50 µg/mL)Product nameDispensing Solutions, Inc.2011-10-06
Latanoprost Ophthalmic Solution 0.005% (50 ug/mL)Product nameRebel Distributors Corp2011-09-13
Latanoprost Ophthalmic Solution 0.005% (50 ug/mL)Product namePhysicians Total Care, Inc.2011-04-18